Serum IGF-binding protein 2 (IGFBP-2) concentrations change early after gastric bypass bariatric surgery revealing a possible marker of leptin sensitivity in obese subjects

[1]  K. Rahmouni,et al.  The cellular and molecular bases of leptin and ghrelin resistance in obesity , 2017, Nature Reviews Endocrinology.

[2]  H. Berthoud,et al.  Does gastric bypass surgery change body weight set point? , 2016, International journal of obesity supplements.

[3]  F. Santini,et al.  Integrating medical and surgical therapies to optimize the outcomes of type 2 diabetes. , 2016, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[4]  Lun Zhang,et al.  IGF-binding protein 2 is a candidate target of therapeutic potential in cancer , 2016, Tumor Biology.

[5]  M. Mokadem,et al.  Leptin Is Required for Glucose Homeostasis after Roux-en-Y Gastric Bypass in Mice , 2015, PloS one.

[6]  A. Hoeflich,et al.  Physiology and pathophysiology of IGFBP-1 and IGFBP-2 - consensus and dissent on metabolic control and malignant potential. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[7]  W. Kraus,et al.  Simultaneous Consideration of Multiple Candidate Protein Biomarkers for Long-Term Risk for Cardiovascular Events , 2015, Circulation. Cardiovascular genetics.

[8]  F. Santini,et al.  Fuel homeostasis and locomotor behavior: role of leptin and melanocortin pathways , 2015, Journal of Endocrinological Investigation.

[9]  E. Livingston,et al.  Association between bariatric surgery and long-term survival. , 2015, JAMA.

[10]  J. Després,et al.  Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides. , 2014, Atherosclerosis.

[11]  F. Dunshea,et al.  IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes , 2014, International Journal of Obesity.

[12]  H. Berthoud,et al.  Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery , 2014, International Journal of Obesity.

[13]  J. Després,et al.  CIRCULATING IGFBP-2 LEVELS ARE INCREMENTALLY LINKED TO CORRELATES OF THE METABOLIC SYNDROME AND INDEPENDENTLY ASSOCIATED WITH VLDL TRIGLYCERIDES , 2014 .

[14]  M. Anselmino,et al.  Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass , 2014, Surgical Endoscopy.

[15]  G. McConell,et al.  Leptin enhances insulin sensitivity by direct and sympathetic nervous system regulation of muscle IGFBP-2 expression: evidence from nonrodent models. , 2014, Endocrinology.

[16]  G. Werther,et al.  IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells , 2014, Oncogene.

[17]  Scott D Covey,et al.  IGFBP2 is neither sufficient nor necessary for the physiological actions of leptin on glucose homeostasis in male ob/ob mice. , 2014, Endocrinology.

[18]  L. Maile,et al.  The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice. , 2013, Endocrinology.

[19]  S. Bens,et al.  DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. , 2013, Cell metabolism.

[20]  L. Aronne,et al.  RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY of LEPTIN ADMINISTRATION after GASTRIC BYPASS , 2013, Obesity.

[21]  M. Haluzík,et al.  Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: The influence of very-low-calorie diet , 2012, Molecular and Cellular Endocrinology.

[22]  P. Poirier,et al.  Upregulation of Plasma Insulin‐Like Growth Factor Binding Protein 2 Levels After Biliopancreatic Diversion in Humans , 2012, Obesity.

[23]  R. Bergman,et al.  Mechanisms Responsible for Excess Weight Loss after Bariatric Surgery , 2011, Journal of diabetes science and technology.

[24]  J. Dixon,et al.  Surgical approaches to the treatment of obesity , 2011, Nature Reviews Gastroenterology &Hepatology.

[25]  J. Friedman.  Leptin and the regulation of body weigh. , 2011, The Keio journal of medicine.

[26]  A. Geliebter,et al.  Changes in neurohormonal gut peptides following bariatric surgery , 2011, International Journal of Obesity.

[27]  F. Picard,et al.  Modulation of IGFBP2 mRNA expression in white adipose tissue upon aging and obesity. , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[28]  J. Teixeira,et al.  Superior Appetite Hormone Profile After Equivalent Weight Loss by Gastric Bypass Compared to Gastric Banding , 2010, Obesity.

[29]  W. Ruan,et al.  Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome? , 2010, Acta Diabetologica.

[30]  R. Wysocki,et al.  Antidiabetic effects of IGFBP2, a leptin-regulated gene. , 2010, Cell metabolism.

[31]  M. Kearney,et al.  IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis , 2009, Trends in Endocrinology & Metabolism.

[32]  H. Ariga,et al.  PAPA-1 Is a nuclear binding partner of IGFBP-2 and modulates its growth-promoting actions. , 2009, Molecular endocrinology.

[33]  L. Sjöström.  Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study , 2008, International Journal of Obesity.

[34]  C. Weyer,et al.  Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms. , 2008, Endocrinology.

[35]  C. Morrison.  Leptin resistance and the response to positive energy balance , 2008, Physiology & Behavior.

[36]  Christian Weyer,et al.  Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies , 2008, Proceedings of the National Academy of Sciences.

[37]  Antonio Vidal-Puig,et al.  IGF-Binding Protein-2 Protects Against the Development of Obesity and Insulin Resistance , 2007, Diabetes.

[38]  G. Davey Smith,et al.  Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort. , 2006, The Journal of clinical endocrinology and metabolism.

[39]  A. Hoeflich,et al.  IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. , 2006, Journal of molecular endocrinology.

[40]  D. Cummings,et al.  Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. , 2004, The Journal of clinical endocrinology and metabolism.

[41]  N. Socci,et al.  Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. , 2004, The Journal of clinical investigation.

[42]  M. Elmlinger,et al.  Significance of Basal IGF-I, IGFBP-3 and IGFBP-2 Measurements in the Diagnostics of Short Stature in Children , 2001, Hormone Research in Paediatrics.

[43]  J. Frystyk,et al.  Circulating levels of free insulin‐like growth factors in obese subjects: the impact of Type 2 diabetes , 1999, Diabetes/metabolism research and reviews.

[44]  S. Mohan,et al.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. , 1997, Endocrine reviews.

[45]  R. Considine,et al.  Leptin and the regulation of body weight. , 1997, The international journal of biochemistry & cell biology.

[46]  D. Clemmons,et al.  Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. , 1995, The Journal of clinical endocrinology and metabolism.

[47]  B. Moats-Staats,et al.  Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. , 1994, Endocrinology.

[48]  S. Hughes,et al.  Effect of secretagogues on cytosolic free Ca2+ and insulin release in the hamster clonal beta-cell line HIT-T15. , 1988, Journal of molecular endocrinology.

[49]  P. Neri,et al.  Studies on the stability of rat testis membrane receptors for hLH, hCG and hFSH , 1979, Journal of endocrinological investigation.

[50]  C. Cavallero,et al.  Morfologia funzionale delle isole pancreatiche , 2005, Acta diabetologia latina.

[51]  T. Aoki,et al.  PATHOLOGICAL STUDIES ON MALNUTRITION PARTICULARLY THE PATHOLOGY OF THE LIVER AND KIDNEY , 1952 .